Hannah Joseph Hospital IPO
Market Sentiment
Market Lot Size
IPO Details
IPO Reservation
Financial Analysis
| Metric | 2023 | 2024 | 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 54.90 | 63.63 | 77.90 | 42.75 |
| Expense | 53.88 | 58.29 | 67.55 | 35.70 |
| Profit (PAT) | 1.01 | 4.07 | 7.21 | 5.12 |
| Total Assets | 92.14 | 89.97 | 99.29 | 104.58 |
| Company | P/E | EPS | Market Cap (Cr) |
|---|---|---|---|
| Asarfi Hospital Limited | 32.26 | 5.58 | 13 |
| Maitreya Medicare Limited | 74.29 | 2.80 | 7 |
Promoters: Mosesjoseph Arunkumar, Fenn Kavitha Fenn Arunkumar, Arunkumar Nalina and Noyel Arunkumar
| Shareholding | No. of Shares | Holding % |
|---|---|---|
| Promoter Holding Pre Issue | 1,66,98,363 | 93.57% |
| Promoter Holding Post Issue | 2,26,98,363 | 68.83% |
Company Information
Hannah Joseph Hospital Limited, founded in 2011, is one of the growing medical and healthcare services provider in India. The company offers medical services across various departments, such as Neurology, Cardiology, Psychiatry, and Trauma healthcare. Hannah Joseph is a Multi-Specialty hospital situated in Madurai with a 2-acre campus. The business has a total of 364 employees as of 2025. The healthcare hospital is equipped with central air-conditioning, a water heating system, and a combined capacity of 150 beds. Moreover, the company has been renowned for offering 24/7 Emergency care, 30+ world-class amenities, and 70+ specialized doctors to provide quality healthcare at affordable prices.
| Purpose | Amount (Cr) |
|---|---|
| Funding of capital expenditure for establishing Radiation Oncology Centre | 34.98 |
| General Corporate Purpose | - |
Resources & Documents
Hannah Joseph Hospital Ltd., Address: 134,Lake View Road, K.K. Nagar,Madurai, Tamil Nadu,625020, Website https://hannahjosephhospital.com/
Hannah Joseph Hospital has set a price band of Rs 67–Rs 70 per share for an issue size of Rs 42 crore in the healthcare sector. The stock listed with a 2.50% discount versus its issue price on February 02, 2026.
Hannah Joseph Hospital Limited, founded in 2011, is one of the growing medical and healthcare services provider in India. The company offers medical services across various departments, such as Neurology, Cardiology, Psychiatry, and Trauma healthcare. The company operates in the healthcare space.
The issue is promoted by Mosesjoseph Arunkumar, Fenn Kavitha Fenn Arunkumar, Arunkumar Nalina and Noyel Arunkumar with Capital Square Advisors Pvt.Ltd acting as lead manager. Net proceeds will primarily be used towards Funding of capital expenditure for establishing Radiation Oncology Centre (Rs 35 crore) and General Corporate Purpose.
Final subscription data records overall subscription at 1.62x, retail at 1.62x, QIB at 1.08x, NII at 2.34x.
On fundamentals, the company is posting revenue growth of 22.4%, a profit margin of 9.3%, return on equity of 14.8% in its most recent reported period. Listed peers in this segment include Asarfi Hospital Limited (P/E 32.26x, market cap Rs 13 crore) and Maitreya Medicare Limited (P/E 74.29x, market cap Rs 7 crore) — useful reference points when evaluating the issue's pricing relative to where the broader sector are trading.
Our data-driven engine currently flags this issue as an Avoid view — key indicators are weak enough that the risk-reward looks unfavourable for now. Past performance does not predict future returns — review the price chart and peer comparison below before trading.
Understanding Grey Market Premium (GMP)
The Grey Market Premium (GMP) is an unofficial indicator of how an IPO's shares are trading in the grey market before they are officially listed on a stock exchange. It reflects investor sentiment and demand for the IPO shares ahead of listing day.
How does it work? The grey market is an informal, over-the-counter market where investors buy and sell IPO shares before the official listing date. If an IPO has a positive GMP, it suggests that investors expect the stock to list above its issue price. A negative GMP indicates expectations of a listing below the issue price.
Example: If an IPO has an issue price of ₹100 and the GMP is ₹50, the expected listing price would be approximately ₹150 (issue price + GMP). This translates to an estimated listing gain of 50%.
Factors that influence GMP:
- Subscription levels — Higher subscription typically drives GMP up
- Market conditions — Bullish markets tend to boost GMP across all IPOs
- Company fundamentals — Strong financials and growth potential attract premium
- Industry sentiment — Positive outlook for the sector can increase demand
- IPO pricing — Reasonably priced IPOs relative to peers tend to command higher GMP
Disclaimer: GMP is an unofficial metric from the grey market and is not regulated by SEBI or any stock exchange. GMP values fluctuate frequently and should not be the sole basis for investment decisions. Always consider company fundamentals, financial health, and your own risk appetite before investing in any IPO.
Related IPO
No comments yet. Be the first to share your opinion!